Literature DB >> 2144757

Low-dose fortnightly methotrexate in advanced prostate cancer. The EORTC Genito-Urinary Tract Cancer Cooperative Group.

W G Jones, S D Fosså, A C Verbaeys, J P Droz, J G Klijn, E Boven, M de Pauw, R Sylvester.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2144757     DOI： 10.1016/0277-5379(90)90099-f

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

1.  Dietary folate deficiency blocks prostate cancer progression in the TRAMP model.

Authors:  Gaia Bistulfi; Barbara A Foster; Ellen Karasik; Bryan Gillard; Jeff Miecznikowski; Vineet K Dhiman; Dominic J Smiraglia
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-11

2.  Palliative low dose fortnightly methotrexate in oral cancer.

Authors:  Sim Sai Tin; Viroj Wiwanitkit
Journal:  South Asian J Cancer       Date:  2015 Oct-Dec

3.  Dietary folate levels alter the kinetics and molecular mechanism of prostate cancer recurrence in the CWR22 model.

Authors:  Hayley C Affronti; Mark D Long; Spencer R Rosario; Bryan M Gillard; Ellen Karasik; Christoph S Boerlin; Anthony J Pellerite; Barbara A Foster; Kristopher Attwood; Roberto Pili; John H Wilton; Moray J Campbell; Dominic J Smiraglia
Journal:  Oncotarget       Date:  2017-10-20

Review 4.  One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling.

Authors:  Joshua M Corbin; Maria J Ruiz-Echevarría
Journal:  Int J Mol Sci       Date:  2016-07-27       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.